StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.40−0.33 (-0.58%)

Close on Nov 18, 2026Market cap $5.05BP/E 40.6Yield –

Liquidia operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Liquidia's operating income for the twelve months ending Jun 30, 2026 was $168.58M. For fiscal 2025 it was -$51.38M. The highest annual figure on record is -$33.80M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.38M–
FY2024Dec 31, 2024-$121.29M–
FY2023Dec 31, 2023-$73.38M–
FY2022Dec 31, 2022-$38.77M–
FY2021Dec 31, 2021-$33.80M–
FY2020Dec 31, 2020-$59.09M–
FY2019Dec 31, 2019-$46.82M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$85.52M–
Q1 FY2026Mar 31, 2026$61.50M–
Q4 FY2025Dec 31, 2025$19.79M–
Q3 FY2025Sep 30, 2025$1.77M–
Q2 FY2025Jun 30, 2025-$37.51M–
Q1 FY2025Mar 31, 2025-$35.43M–
Q4 FY2024Dec 31, 2024-$36.11M–
Q3 FY2024Sep 30, 2024-$29.19M–
Q2 FY2024Jun 30, 2024-$27.20M–
Q1 FY2024Mar 31, 2024-$28.80M–
Q4 FY2023Dec 31, 2023-$26.44M–
Q3 FY2023Sep 30, 2023-$14.89M–
Q2 FY2023Jun 30, 2023-$22.83M–
Q1 FY2023Mar 31, 2023-$9.23M–
Q4 FY2022Dec 31, 2022-$6.50M–
Q3 FY2022Sep 30, 2022-$8.83M–
Q2 FY2022Jun 30, 2022-$8.97M–
Q1 FY2022Mar 31, 2022-$14.47M–
Q4 FY2021Dec 31, 2021-$11.36M–
Q3 FY2021Sep 30, 2021-$7.08M–
Q2 FY2021Jun 30, 2021-$6.35M–
Q1 FY2021Mar 31, 2021-$9.00M–
Q4 FY2020Dec 31, 2020-$15.91M–
Q3 FY2020Sep 30, 2020-$14.81M–
Q2 FY2020Jun 30, 2020-$13.72M–
Q1 FY2020Mar 31, 2020-$14.65M–

More Liquidia figures

See a number that looks wrong?